Buscar
Mostrando ítems 1-10 de 20
What are the effects of zonisamide add-on therapy for people with uncontrolled focal epilepsy?
(Wiley, 2019-06)
Compared with placebo, for people (mostly adolescents and adults) with focal epilepsy uncontrolled by at least one antiepileptic drug, moderate‐certainty evidence shows that zonisamide led to more people achieving a reduction ...
Determination of levetiracetam in human plasma by dispersive liquid-liquid microextraction followed by gas chromatography-mass spectrometry
(Univ Sao Paulo, Inst Psiquiatria, 2016)
Levetiracetam (LEV) is an antiepileptic drug that is clinically effective in generalized and partial epilepsy syndromes. The use of this drug has been increasing in clinical practice and intra- or -interindividual variability ...
Drugs commonly associated with weight change: A systematic review and meta-analysis
(Oxford University Press, 2015)
Context: Various drugs affect body weight as a side effect. Objective: We conducted this systematic review and meta-analysis to summarize the evidence about commonly prescribed drugs and their association with weight change. ...
Excitotoxicity as a target against neurodegenerative processes
(Bentham Science Publishers, 2020)
No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine
(Blackwell Publishing Inc., 2016)
Approaches for the development of drugs for treatment of obesity and metabolic syndrome
(Bentham Science Publishers, 2016)
How does levetiracetam compare with other anti-epileptic drugs in terms of congenital malformations in children?
(Wiley, 2019-06)
Reviewers assessed the incidence of congenital malformations in children associated with levetiracetam versus carbamazepine, gabapentin, lamotrigine, oxycarbazepine, phenobarbital, phenytoin, topiramate, zonisamide, and ...
Síndrome de reacción a medicamento con eosinofilia y síntomas sistémicos (DRESS) asociado a levetiracetam: Reporte de caso
(Colegio Médico del Pérú, 2023-09-29)
El síndrome de hipersensibilidad a medicamentos, con eosinofilia y síntomas sistémicos (DRESS de sus siglas en inglés) es un síndrome muy infrecuente que se caracteriza por erupción dérmica, eosinofilia y compromiso ...